BPC-157 has been widely studied in preclinical models for its potential role in: Tissue regeneration research (muscle, tendon, and epithelial cells), Gastrointestinal studies, exploring protective effects on gut lining and gastric integrity, Angiogenesis and vascular modulation research, Neuroprotective and anti-inflammatory investigations, These findings support continued interest in understanding BPC-157s interaction with cellular growth and repair pathways in experimental contexts
This evidence gap represents both the compounds promise and its current limitations
Pricing matches the delayed release version at approximately $70-85 for 30 capsules, though the serving count differs between products
In preclinical models, it improved outcomes in inflammatory bowel disease, GI ulcers, NSAID-induced injury, and fistula repair
| Concentration | BAC Water | Doses at 1.0mg | Doses at 2.4mg | |---------------|-----------|----------------|----------------| | 5mg/mL | 2.0mL | 10 doses | ~4 doses | | 2.5mg/mL | 4.0mL | 10 doses | ~4 doses | **Best practice:** 2.0mL BAC water gives a clean 5mg/mL concentration
